This medical device stock looks like a gift for patient investors
Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7%…
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between a high-yield pharmaceutical powerhouse and a diversified healthcare leader requires looking at growth and stability. You…
Meta’s latest move in the AI talent war, plus Cramer’s 4 quick hits
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Apple’s China breakthrough provides another tailwind for its stock
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Cramer: The money to AI stocks is a problem, and how it can be fixed
We do not have enough money coming into this market. The funds flow only to stocks tied to…
Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love
Both Abbott Laboratories (ABT) and Boston Scientific (BSX) trade at or near 52-week lows while Wall Street analysts…
Stock market today: Live updates
Traders celebrating at the New York Stock Exchange on April 15, 2026, as the S&P 500 (^GSPC) closed…
Abbott closing Exact Sciences acquisition next week | News
MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.…
Retirement is changing. Here’s why companies need to change, too
America’s workforce is on the verge of an unprecedented transformation. More Americans are turning 65 in 2025 than…
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…
Here are the 3 big things we’re watching in the stock market in this week
Last week started with the big banks delivering strong earnings and ended with regional lenders writing off bad…